Nutex Health Q3 2025 revenue $267.8M (+240% YoY), net income $55.4M vs loss $8.8M

Nutex Health Inc.

2025-Q3 EPS reported $8.87 revenue$723,578,000

Total revenue $267.8M for Q3 2025, up 240% YoY; hospital division revenue $260.2M, up 263% YoY.
Net income attributable to Nutex of $55.4M in Q3 2025 vs net loss of $8.8M in Q3 2024; diluted EPS $7.76.
Adjusted EBITDA attributable to Nutex of $98.5M in Q3 2025 vs $9.7M in Q3 2024.
YTD 2025: revenue $723.6M (+225%), net income $59.0M vs loss $9.5M, adjusted EBITDA $243.0M.
Regained Nasdaq compliance on Nov 19, 2025 after filing delinquent 10-Q; matter closed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.